The Mission of RoPlaVac is: • to establish an internationally recognized new paradigm in malaria vaccination.
• to develop a vaccine against malaria that can simultaneously protect
against the two major species of malaria-causing parasites. • to provide this vaccine at affordable prices to the populations in malaria-endemic regions.
RoPlaVac Project aims to develop and validate a novel vaccination
strategy against malaria, one of the world's deadliest diseases.
2013 - National BES Innovation Contest,
1st Prize for the Health Track and Winner of the Grand Prize, Concurso
Nacional de Inovação do Banco Espirito Santo, November 2013, Lisboa,
Portugal. Photo 1 here; Photo 2 here